Form D · Pharmaceuticals
PharmassetX Inc.
Louisville, KY · CIK 0002090938
Offering snapshot reported May 4, 2026 · SEC filing
- Reported sold
- $100K Offering amount: $6M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 30, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 4, 2026 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Oct 10, 2025 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-582743
Simple Agreement for Future Equity (SAFE)
Source: Form D, filed May 4, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gerald Dryden | Director, Executive |
| David Mc Clure | Director, Executive |
| Terry Minton | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2900 Lake Vista Drive
Louisville, KY, 40241
Phone: (502) 939-1925
Louisville, KY, 40241
Phone: (502) 939-1925